136 related articles for article (PubMed ID: 35572890)
1. Effects of Kangdaxin on myocardial fibrosis in heart failure with preserved ejection fraction rats.
Wu X; Zhang T; Qiao J; Li C; Lin C; Xiong S
J Thorac Dis; 2022 Apr; 14(4):1157-1163. PubMed ID: 35572890
[TBL] [Abstract][Full Text] [Related]
2. Effects and mechanism of Compound Qidan Formula on rats with HFpEF induced by hypertension and diabetes mellitus based on Ang Ⅱ/TGF-β1/Smads signaling pathway.
Yuan P; Liu J; Xiong S; Yang L; Guan J; Dong G; Shi D
J Ethnopharmacol; 2023 Sep; 313():116558. PubMed ID: 37116729
[TBL] [Abstract][Full Text] [Related]
3. [Effect of sacubitril/valsartan on cardiac function in heart failure rabbits with preserved ejection fraction].
Gao SY; Yao DH; Li JF; Xie QM; Jiang SC
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):887-893. PubMed ID: 31744278
[No Abstract] [Full Text] [Related]
4. Association of Diastolic Dysfunction with N-terminal Pro-B-type Natriuretic Peptide Level in Heart Failure Patients with Preserved Ejection Fraction.
Islam MN; Chowdhury MS; Paul GK; Debnath RC; Shakil SS
Mymensingh Med J; 2019 Apr; 28(2):333-346. PubMed ID: 31086148
[TBL] [Abstract][Full Text] [Related]
5. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction.
Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S
Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551
[TBL] [Abstract][Full Text] [Related]
6. Twist/untwist parameters are promising evaluators of myocardial mechanic changes in heart failure patients with preserved ejection fraction.
Zhang Y; Li SY; Xie JJ; Wu Y
Clin Cardiol; 2020 Jun; 43(6):587-593. PubMed ID: 32212277
[TBL] [Abstract][Full Text] [Related]
7. Qiliqiangxin capsule improves cardiac remodeling in rats with DOCA-salt-induced diastolic dysfunction.
Hao JM; Sun P; Zeng Y; Zhang H; Zhang ZD; Chang LP; Hou YL
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(15):7264-7275. PubMed ID: 37606135
[TBL] [Abstract][Full Text] [Related]
8. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
[TBL] [Abstract][Full Text] [Related]
9. Diastolic stress test echocardiography in patients with suspected heart failure with preserved ejection fraction: a pilot study.
Belyavskiy E; Morris DA; Url-Michitsch M; Verheyen N; Meinitzer A; Radhakrishnan AK; Kropf M; Frydas A; Ovchinnikov AG; Schmidt A; Tadic M; Genger M; Lindhorst R; Bobenko A; Tschöpe C; Edelmann F; Pieske-Kraigher E; Pieske B
ESC Heart Fail; 2019 Feb; 6(1):146-153. PubMed ID: 30451399
[TBL] [Abstract][Full Text] [Related]
10. [Role of ACE2-Ang (1-7)-Mas receptor axis in heart failure with preserved ejection fraction with hypertension].
Yu J; Wu Y; Zhang Y; Zhang L; Ma Q; Luo X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):738-746. PubMed ID: 30124209
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
[TBL] [Abstract][Full Text] [Related]
12. Multilayer myocardial strain improves the diagnosis of heart failure with preserved ejection fraction.
Tanacli R; Hashemi D; Neye M; Motzkus LA; Blum M; Tahirovic E; Dordevic A; Kraft R; Zamani SM; Pieske B; Düngen HD; Kelle S
ESC Heart Fail; 2020 Oct; 7(5):3240-3245. PubMed ID: 32567247
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of N-terminal B-type natriuretic peptide on all-cause mortality in heart failure patients with preserved ejection fraction].
Cao J; Jin XJ; Zhou J; Chen ZY; Xu DL; Yang XC; Dong W; Li LW; Luo J; Chen L; Fu M; Zhou JM; Ge JB
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):875-881. PubMed ID: 31744276
[No Abstract] [Full Text] [Related]
14. Shunxin decoction improves diastolic function in rats with heart failure with preserved ejection fraction induced by abdominal aorta constriction through cyclic guanosine monophosphate-dependent protein kinase Signaling Pathway.
Jiaying Z; Xiangxiang W; Xuefeng LI; Yang Y; Yinghuan D; Yanbin S; Ping X; Mengru Z; Junnan Z; Miao LI; Shuwen Z; Rui Z; Ying T; Hao T; Feifei T
J Tradit Chin Med; 2022 Oct; 42(5):764-772. PubMed ID: 36083484
[TBL] [Abstract][Full Text] [Related]
15. Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure.
Zhang J; Xu M; Chen T; Zhou Y
Front Cardiovasc Med; 2021; 8():748173. PubMed ID: 34901210
[No Abstract] [Full Text] [Related]
16. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of NT-proBNP, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction.
Blanco R; Ambrosio G; Belziti C; Lucas L; Arias A; D'Antonio A; Oberti P; Carluccio E; Pizarro R
Int J Cardiol; 2020 Oct; 317():111-120. PubMed ID: 32380249
[TBL] [Abstract][Full Text] [Related]
18. [Study on mechanisms and myocardial protective effect of Qishen Yiqi dropping pills on rats with myocardial infarction].
Yang Q; Cao Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):501-505. PubMed ID: 28625237
[TBL] [Abstract][Full Text] [Related]
19. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
[TBL] [Abstract][Full Text] [Related]
20. Association of a Novel Diagnostic Biomarker, the Plasma Cardiac Bridging Integrator 1 Score, With Heart Failure With Preserved Ejection Fraction and Cardiovascular Hospitalization.
Nikolova AP; Hitzeman TC; Baum R; Caldaruse AM; Agvanian S; Xie Y; Geft DR; Chang DH; Moriguchi JD; Hage A; Azarbal B; Czer LS; Kittleson MM; Patel JK; Wu AHB; Kobashigawa JA; Hamilton M; Hong T; Shaw RM
JAMA Cardiol; 2018 Dec; 3(12):1206-1210. PubMed ID: 30383171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
